Azathioprine

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

Medicine purchases: ATC L04AX01
Medicine purchases: ATC: other data required >3 instances required

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector RX_L04AX01

Extra metadata

First used in FinnGen datafreeze DF4

Summary Statistics

Key figures

All Female Male
Number of individuals 3539 2028 1511
Unadjusted prevalence (%) 1.36 1.38 1.34
Mean age at first event (years) 44.47 43.84 45.32

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 2.78 [1.93, 4.01] 3.9e-8 208
15 years 0.02 3.28 [2.40, 4.48] 1.1e-13 169
5 years 0.01 4.78 [3.41, 6.69] 8.4e-20 70
1 year 0.00 3.60 [1.85, 7.00] 1.6e-4 10

Correlations

Index endpoint: RX_L04AX01 – Azathioprine
GWS hits:

Survival analyses between endpoints

Plot

before Azathioprine
after Azathioprine

loading spinner Loading survival analyses plot